Imran Khan government has sought India’s help in combating the pandemic. According to a report published by India TV, Pakistan has formally requested India for the drug Hydroxychloroquine (HCQ), believed to be helpful in treating the COVID-19.
Pakistan is the latest entrant to the list to countries who have sought consignments of the drug from India which is thought to have a salutary effect in the treatment against the coronavirus. Earlier, the United States and Brazil requested India for stocks of Hydroxychloroquine for treatment of coronavirus in their countries. The demand from Pakistan came after it witnessed a sharp rise as the number of coronavirus cases touched 6000-mark and the number of fatalities crossed 100.
India is the largest producer of the anti-malarian anti-arthritis drug and had recently put a ban on its exports. However, after US President Donald Trump’s request for the drug and assurance of the manufacturers that India have sufficient stock cater to both domestic and export demand, India partially lifted the restrictions on its export and fulfilled several country’s requests for the HCQ tablets. India had recently also declared that it will be exporting the HCQ drug and other medicines to its neighbours-Nepal, Bhutan and Bangladesh as they completely depend on India for their pharmaceuticals. In addition, India has also agreed to sell the anti-malarian drug touted to cure coronavirus to Malaysia as well.
Post Your Comments